Contact this trialFirst, we need to learn more about you.
Antidepressant
Antidepressant Medications +1 More for Type 2 Diabetes
Recruiting1 awardPhase 2
Indianapolis, Indiana
This trial will test whether a modernized collaborative care intervention for depression can improve the diabetes risk markers of hemoglobin A1c and insulin resistance, and whether somatic depressive symptoms moderate the effect of the intervention on diabetes risk markers.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.